"This latest health care price growth report indicates that spending on pricey prescription medications shows no sign of slowing down. When compared to other health care services, it is clear that high cost treatments continue to top the charts as a serious threat to the sustainability of our health care system and beyond." Read More
“Breakthrough treatments such as Praluent hold tremendous medical promise for certain patients, but it’s price tag makes us question how long the health system can sustain these costs for patients managing chronic conditions over several years.” Read More
“Breakthrough treatments such as Praluent hold tremendous medical promise for certain patients, but its price tag makes us question how long the health system can sustain these costs for patients managing chronic conditions over several years," John Rother, president of the National Coalition on Health Care, said in a statement. Read More
John Rother, President of the National Coalition on Health Care and Chair of the Campaign for Sustainable Rx Pricing issued the following statement in response to a recent health tracking poll by the Kaiser Family Foundation that found that an overwhelming 76% of Americans blame pharmaceutical companies for the rising cost of medicines. Read More
May 20, 2015 “Prescription drug prices climb into the stratosphere”… Read More
May 13, 2015 New Drug Report Reveals Drug Costs Top $50,000/year for Over Half… Read More
Reaction from National Coalition on Health Care President and CEO John Rother… Read More
John Rother to Make Appearances at AMA National Advocacy Conference and National Conference of Insurance Legislators. Read More